Vicarious Surgical (NYSE:RBOT – Get Rating) and NanoVibronix (NASDAQ:NAOV – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, profitability and risk.
Volatility & Risk
Vicarious Surgical has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. Comparatively, NanoVibronix has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500.
Earnings and Valuation
This table compares Vicarious Surgical and NanoVibronix’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Vicarious Surgical||N/A||N/A||-$35.21 million||$0.20||19.80|
|NanoVibronix||$1.70 million||7.65||-$14.28 million||N/A||N/A|
This is a summary of recent recommendations and price targets for Vicarious Surgical and NanoVibronix, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Vicarious Surgical presently has a consensus price target of $10.75, indicating a potential upside of 171.46%. Given Vicarious Surgical’s higher possible upside, analysts plainly believe Vicarious Surgical is more favorable than NanoVibronix.
This table compares Vicarious Surgical and NanoVibronix’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Institutional & Insider Ownership
51.8% of Vicarious Surgical shares are owned by institutional investors. Comparatively, 5.2% of NanoVibronix shares are owned by institutional investors. 52.5% of Vicarious Surgical shares are owned by insiders. Comparatively, 5.6% of NanoVibronix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Vicarious Surgical beats NanoVibronix on 8 of the 10 factors compared between the two stocks.
About Vicarious Surgical
Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.